期刊文献+

氯氮平引起脑电图异常及癫疒间发作回顾研究 被引量:2

A retrospective study of clozapine induced electroencephalographic (EEG) abnormality and seizure in psychiatric patients
下载PDF
导出
摘要 目的:调查氯氮平引起脑电图异常率和癫疒间发生率,及相关影响因素。方法:共调查331例服氯氮平后且在电休克治疗1个月外有脑电图的病历。结果:脑电图的异常率是30.21%(100/331),癫疒间发生率为0.91%(3/331)。在≤450mg/d剂量范围内,脑电图异常率以及异常程度随剂量增加而增加,差异具有统计学意义。服氯氮平后半月内以及2年以上的脑电图异常率比其他时间低。结论:服用氯氮平治疗患者的脑电图异常率高达30.21%,癫疒间发生率为0.91%。在一定剂量范围内脑电图异常率及异常程度随氯氮平剂量增加而增加。脑电图异常率差异随服用氯氮平时间不同而不同。 Objective: The aim of this paper was to investigate the incidence and influence of the clozapine-induced electroencephalographic (EEG) abnormality and seizure. Method:331 Patients were enrolled in the study whose EEGs were examined after one month's ECT. Results:The incidence of EEG abnormalities and seizure was 30.21% (100/331),0.91%(3/331) respectively.It was showed that higher daily dose of clozapine was,the greater risk of abnormal EEG and more severity may be within the doseage of 450 mg/d.The incidence of EEG abnormalities and severity of abnormal EEG are different significantly among different groups of clozapine duration.The incidence of EEG abnormalities was lower within 2 weeks and more than 2 years. Conclusion:The higher daily dose of clozapine was,the greater risk of abnormal EEG and seizure may be,and the more severity of abnormal EEG may be.The incidence was significantly related with duration clozapine.
出处 《临床精神医学杂志》 2013年第2期129-131,共3页 Journal of Clinical Psychiatry
关键词 氯氮平 脑电图 癫疒间发作 clozapine electroencephalographic seizure
  • 相关文献

参考文献6

二级参考文献30

  • 1杨茹斌.氯氮平与氯丙嗪对脑电图影响的对比研究[J].精神医学杂志,1992,18(1):30-31. 被引量:1
  • 2司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 3况伟宏,张逢春,吕冰,陈应渝,牟绍蓉.氯氮平血药浓度与临床效应关系探讨[J].中国神经精神疾病杂志,1994,20(3):145-147. 被引量:18
  • 4曾昭祥,袁学明,刘琳,曹中昌,马恩轩,吕新武.常用精神药物对脑电图的影响[J].四川精神卫生,1995,8(2):92-93. 被引量:5
  • 5王援朝.氯氮平不同剂量对脑电图影响的比较[J].临床精神医学杂志,1995,5(1):5-5.
  • 6Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
  • 7Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
  • 8Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
  • 9Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
  • 10Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.

共引文献117

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部